Advertisement

Drug Investigation

, Volume 8, Supplement 1, pp 47–52 | Cite as

An Overview of the Clinical Experience of Secnidazole in Giardiasis and Amoebiasis

  • David Botero
Article
  • 21 Downloads

Summary

The experience of the present author in the treatment of 100 patients with symptomatic intestinal amoebiasis demonstrated a clinical cure rate of 83% and a parasitological cure rate of 88% when assessed on day 5 following single dose administration of secnidazole 2g. When 50 asymptomatic amoeba cyst carriers treated with single dose secnidazole 30 mg/kg/bodyweight were compared with 50 similar patients receiving placebo, it was found that 56% of the first group and 24% of the second group became negative, a statistically significant difference favouring those receiving secnidazole. Seven papers dealing with the treatment of acute or chronic amoebiasis were reviewed, and all showed similar or superior results to those of the present author. Four published comparative studies of secnidazole and other amoebicides were also reviewed, all demonstrating superior results with secnidazole.

Studies by this author of 155 children presenting with giardiasis demonstrated parasitological cure in more than 90%, a finding confirmed in the literature. The safety and tolerability of secnidazole were good. No toxic effects were found, and side effects were present in less than one-fourth of patients, involving mainly gastrointestinal symptoms and a metallic taste. All side effects were of mild intensity and did not require specific treatment.

Keywords

Metronidazole Drug Invest Tinidazole Giardiasis Clinical Cure Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Botero D, Giraldo J, Guzmán R. Tratamiento de la amibiasis intestinal con secnidazole. Estudio de 100 casos con amibiasis aguda no complicada. Medicina UPB Colombia 1991; 10: 49–53Google Scholar
  2. 2.
    Botero D, Gómez H, Trujillo J, et al. Tratamiento de amibiasis intestinal con secnidazol II. Estudio doble ciego en portadores asintomáticos. Acta Médica Colombiana 1990; 15: 204–7Google Scholar
  3. 3.
    Botero D, Bravo C, Pérez A. Metronidazol en el tratamiento de colitis amibiana disentérica y no disentérica y de giardiasis. Antioquia Médica 1971; 21: 801–10Google Scholar
  4. 4.
    Botero D. Double blind study with a new nitroimidazole derivative RO 7-0207, versus metronidazole in symptomatic intestinal amebiasis. Am J Trop Med Hyg 1974; 23: 1000–1PubMedGoogle Scholar
  5. 5.
    Andre LJ. Traitment de l’amibiase par le secnidazole. Ann Gastroenterol Hepatol 1979; 15: 221–5Google Scholar
  6. 6.
    da Cunha AS, da Silva EF, Raso P, et al. Availacao terapeutica do composto imidazolico R.P. 14539 na amebiase intestinal. Rev Inst Med Trap Sao Paulo 1977; 19: 342–8Google Scholar
  7. 7.
    Paz-Moreno L, Abreu LM. Amebiasis intestinal aguda en adultos. Eficacia del tratamiento con dosis única de secnidal. Tribuna Médica Mexico 1990; 82: 49–51Google Scholar
  8. 8.
    Botero D, Abreu LM, Cardoso-Salles JM. Efficacy and safety of a single dose of secnidazole in the treatment of acute uncomplicated intestinal amoebiasis in Latin America: a multicenter study. Symposium Proceedings, 16th International Congress of Chemotherapy, Jerusalem. Excerpta Medica 1989; 49–55Google Scholar
  9. 9.
    Restrepo M, Diaz T. Treatment of symptomatic intestinal amoebiasis with a single dose of secnidazole in children. Personal communication. Colombian Institute for Tropical Medicine, PO Box 52162 Medellín, Colombia, 1994Google Scholar
  10. 10.
    Spillmann R, Ayala SC, Sanchez CE. Double-blind test of metronidazole and tinidazole in the treatment of asymptomatic Entamoeba histolytica and Entamoeba hartmanni carriers. Am J Trop Med Hyg 1976; 25: 549–51PubMedGoogle Scholar
  11. 11.
    Latonio AA. Efficacy of a single dose of secnidazole in the treatment of acute and chronic amoebiasis. J Trop Med Hyg 1988; 91: 202–4PubMedGoogle Scholar
  12. 12.
    Soedin K, Alfien-Syukran OK, Fadillah A, et al. Comparison between the efficacy of a single dose of secnidazole with a 5-day course of tetracycline and clioquinol in the treatment of acute intestinal amoebiasis. Pharmatherapeutica 1985; 4: 251–4PubMedGoogle Scholar
  13. 13.
    Soedin K, Lelo A. A single dose of secnidazole vs a 5-day regimen of the combination tetracycline/clioquinol in the treatment of intestinal amoebiasis. Symposium Proceedings, 16th International Congress of Chemotherapy, Jerusalem. Excerpta Medica 1989; 43–8Google Scholar
  14. 14.
    Abreu LM, Paz Moreno L. Single-dose secnidazole vs two-day therapy with tinidazole in the treatment of intestinal amoebiasis. Symposium Proceedings, 16th International Congress of Chemotherapy, Jerusalem. Excerpta Medica 1989; 56–62Google Scholar
  15. 15.
    Gorbea-Robles M del C, Games-Eternot J, González-Velásquez F, et al. Estudio comparativo en amibiasis y giardiasis intestinal del lactante y pre-escolar: eficacia y tolerancia del secnidazol vs metronidazol y etofamida. Investigación Medica Internacional 1989; 16: 72–82Google Scholar
  16. 16.
    Hill DR. Giardiasis. Issues in diagnosis and management. Infectious diseases clinics of North America. Parasitic Diseases 1993; 7: 503–25Google Scholar
  17. 17.
    Hall A, Nahar Q. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Transactions of the Royal Society of Tropical Medicine and Hygiene 1993; 87: 84–6PubMedCrossRefGoogle Scholar
  18. 18.
    Kollaritsch H, Jeschko E, Widermann G. Albendazole is highly effective against cutaneous larva migrans but not against Giardia infection: results of an open pilot trial in travellers returning from the tropics. Transactions of the Royal Society of Tropical Medicine and Hygiene 1993; 87: 689PubMedCrossRefGoogle Scholar
  19. 19.
    Cimerman B, Boruchovski H, Cury FM, et al. A comparative study of secnidazole and metronidazole in the treatment of giardiasis. Symposium Proceedings, 16th International Congress of Chemotherapy, Jerusalem. Excerpta Medica 1989; 28–42Google Scholar
  20. 20.
    Katz N, Cimerman B, Zingano AG, et al. A clinical trial using secnidazole suspension in children infected with Giardia lamblia. Symposium Proceedings, 16th International Congress of Chemotherapy, Jerusalem. Excerpta Medica 1989; 35–42Google Scholar
  21. 21.
    Rossignol JF, Maisonneuve H, Cho YW. Nitroimidazoles in the treatment of trichomoniasis, giardiasis and amebiasis. Int J Clin Pharmacol Ther Toxicol 1984: 22: 63–72PubMedGoogle Scholar

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • David Botero
    • 1
  1. 1.Colombian Institute for Tropical Medicine, ‘Antonio Roldan Betancur’, Pontificia Bolivariana UniversityMedellinColombia

Personalised recommendations